IceCure expands partnership with Japanese company Terumo
IceCure Medical develops and markets a liquid-nitrogen-based cryoablation therapy for the treatment of benign and cancerous tumours. Credit: Nephron.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
